Pamela A. Moalli, MD, PhD

Dr. Pamela Moalli is a Professor, Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh, Division of Urogynecology & Pelvic Reconstructive Surgery, Magee-Womens Hospital of UPMC.  She holds secondary appointments in the Department of Bioengineering and the McGowan Institute of Regenerative Medicine; Clinical and Translational Institute; Adjunct Professor of Bioengineering at Carnegie Mellon University.  She is the Division Director, Urogynecology and Reconstructive Pelvic Surgery, Vice Chair of Translational Research, and a Primary Member, Magee-Women Research Institute.

Dr. Moalli graduated from Brown University, BA with distinction in Biology, and then attended Northwestern University, MD, PhD in Molecular and Cellular Biology, National Institutes of Health-sponsored Medical Scientist Training Program. She did her residency in Obstetrics & Gynecology at the University of Pittsburgh, Magee-Womens Hospital of UPMC, as well as a Fellowship in Urogynecology and Reconstructive Pelvic Surgery.

Her research interests include pathophysiology of pelvic floor disorders with a focus on pelvic organ prolapse and urinary incontinence; stem cell therapies for vaginal birth injury or vaginal biofabrication; the development of biomaterials for improving outcomes of gynecologic surgeries; and defining mechanisms of maternal birth injury. A research program summary follows:

Translational Research Laboratories in Urogynecology (TRLU):

The overarching goal of this interdisciplinary lab consortium is to contribute insights into the pathogenesis, diagnosis, and treatment of pelvic organ prolapse and urinary incontinence – two common pelvic floor disorders. The main areas of research focus are 1) comprehensive analysis of commonly used biomaterials in urogynecologic procedures 2) defining mechanisms of failure after reconstructive pelvic surgeries, 3) designing novel devices for improving outcomes of reconstructive pelvic surgeries 4) defining mechanisms of maternal birth injury, 5) and vaginal biofabrication. The group has expertise in computational modeling, cellular and molecular biology including both traditional and high throughput platforms, soft tissue mechanics, mechanobiology, tissue regeneration and immunomodulation.

TRLU’s current portfolio of investigations include:

Synthetic materials for urogynecologic applications: The group is a world leader in studies defining the impact of commonly used urogynecologic meshes on the vagina in animal models (primate) and women, modifying the host response to improve long-term outcomes, and developing materials that are designed specifically to match the properties of the vagina.  In ex vivo mechanical tests in conjunction with computational analyses, they have clearly demonstrated that prolapse meshes often have markedly unstable geometries with a dramatic loss of porosity with small applications of tension and that stresses imposed on the vagina by the mesh have significant regional variability. These effects are largely driven by modifiable factors including the pore geometry of the mesh, the degree of tension, and how the mesh is anchored. Indeed, the group’s experimental and computational model predictions of the impact of these mechanical effects are confirmed in mesh explants removed from women with mesh complications which demonstrate buckles, folds, and pore collapse. Using ex vivo mechanical tests in conjunction with animal models and computational analyses, the group has demonstrated that most mesh used for incontinence and prolapse surgery have unstable geometries with a loss of porosity under modest tension. They have demonstrated that this is a mechanism for complications (exposures into the vagina and adjacent organs, and pain). The group is currently developing a new generation of meshes based on elastomeric polymers and stable geometries designed to interact and augment host tissues as an alternative to current polypropylene meshes which plastically deform when loaded. In addition, they are working towards personalized meshes based on 3D modeling of an individual patient’s vagina and specific support defects with the idea that it is unlikely that a single mesh type and geometry is an appropriate match for all women with prolapse.  The group is building more comprehensive computational models to provide insight into mechanisms of maternal injury at the time of vaginal birth.  Finally, they are fabricating synthetic mechanical niches for engraftment of vaginal stem cells for use in vaginal biofabrication.

Dr. Moalli’s publications can be reviewed here.

Additional contact information for Dr. Moalli:

204 Craft Ave, A320
Pittsburgh, PA 15213
Fax 412-641-3580
Admin Coordinator: Kelli Lazar,